company background image
ERIS logo

Eris Lifesciences NSEI:ERIS Stok Raporu

Son Fiyat

₹1.35k

Piyasa Değeri

₹183.4b

7D

4.3%

1Y

54.3%

Güncellenmiş

03 Nov, 2024

Veri

Şirket Finansalları +

Eris Lifesciences Limited

NSEI:ERIS Stok Raporu

Piyasa değeri: ₹183.4b

ERIS Stoklara Genel Bakış

Eris Lifesciences Limited, iştirakleri ile birlikte Hindistan'da kronik ve alt kronik tedaviler için yerli markalı formülasyonlar sunmaktadır.

Eris Lifesciences Limited Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Eris Lifesciences
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı₹1,347.15
52 Haftanın En Yüksek Seviyesi₹1,522.05
52 Haftanın En Düşük Seviyesi₹809.15
Beta0.31
11 Aylık Değişim-0.26%
3 Aylık Değişim24.86%
1 Yıllık Değişim54.31%
33 Yıllık Değişim65.23%
5 Yıllık Değişim223.45%
Halka arzdan bu yana değişim123.97%

Son Haberler & Güncellemeler

Eris Lifesciences Limited Just Missed EPS By 8.6%: Here's What Analysts Think Will Happen Next

Oct 30
Eris Lifesciences Limited Just Missed EPS By 8.6%: Here's What Analysts Think Will Happen Next

A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Oct 15
A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Recent updates

Eris Lifesciences Limited Just Missed EPS By 8.6%: Here's What Analysts Think Will Happen Next

Oct 30
Eris Lifesciences Limited Just Missed EPS By 8.6%: Here's What Analysts Think Will Happen Next

A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Oct 15
A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Limited's (NSE:ERIS) CEO Compensation Looks Acceptable To Us And Here's Why

Sep 19
Eris Lifesciences Limited's (NSE:ERIS) CEO Compensation Looks Acceptable To Us And Here's Why

Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS) As Its Stock Soars 27%

Sep 03
Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS) As Its Stock Soars 27%

Earnings Update: Eris Lifesciences Limited (NSE:ERIS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Aug 05
Earnings Update: Eris Lifesciences Limited (NSE:ERIS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Aug 04
Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Estimating The Intrinsic Value Of Eris Lifesciences Limited (NSE:ERIS)

Jul 13
Estimating The Intrinsic Value Of Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Limited (NSE:ERIS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

May 24
Eris Lifesciences Limited (NSE:ERIS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Why We're Not Concerned About Eris Lifesciences Limited's (NSE:ERIS) Share Price

May 10
Why We're Not Concerned About Eris Lifesciences Limited's (NSE:ERIS) Share Price

An Intrinsic Calculation For Eris Lifesciences Limited (NSE:ERIS) Suggests It's 25% Undervalued

Mar 14
An Intrinsic Calculation For Eris Lifesciences Limited (NSE:ERIS) Suggests It's 25% Undervalued

Analyst Estimates: Here's What Brokers Think Of Eris Lifesciences Limited (NSE:ERIS) After Its Third-Quarter Report

Feb 15
Analyst Estimates: Here's What Brokers Think Of Eris Lifesciences Limited (NSE:ERIS) After Its Third-Quarter Report

Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS)

Dec 28
Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Dec 07
Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Nov 11
Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Jul 20
Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?

Nov 20
Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely

Jun 20
These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely

A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Feb 24
A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Is Now The Time To Put Eris Lifesciences (NSE:ERIS) On Your Watchlist?

Dec 28
Is Now The Time To Put Eris Lifesciences (NSE:ERIS) On Your Watchlist?

Here's Why I Think Eris Lifesciences (NSE:ERIS) Might Deserve Your Attention Today

Sep 23
Here's Why I Think Eris Lifesciences (NSE:ERIS) Might Deserve Your Attention Today

If You Like EPS Growth Then Check Out Eris Lifesciences (NSE:ERIS) Before It's Too Late

May 26
If You Like EPS Growth Then Check Out Eris Lifesciences (NSE:ERIS) Before It's Too Late

Eris Lifesciences Limited (NSE:ERIS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Apr 17
Eris Lifesciences Limited (NSE:ERIS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Eris Lifesciences Limited's (NSE:ERIS) Stock Has Fared Decently: Is the Market Following Strong Financials?

Mar 12
Eris Lifesciences Limited's (NSE:ERIS) Stock Has Fared Decently: Is the Market Following Strong Financials?

Does Eris Lifesciences (NSE:ERIS) Deserve A Spot On Your Watchlist?

Feb 25
Does Eris Lifesciences (NSE:ERIS) Deserve A Spot On Your Watchlist?

Why Eris Lifesciences Limited (NSE:ERIS) Is A Dividend Rockstar

Feb 12
Why Eris Lifesciences Limited (NSE:ERIS) Is A Dividend Rockstar

Eris Lifesciences Limited (NSE:ERIS) Analysts Are Pretty Bullish On The Stock After Recent Results

Jan 30
Eris Lifesciences Limited (NSE:ERIS) Analysts Are Pretty Bullish On The Stock After Recent Results

Read This Before Buying Eris Lifesciences Limited (NSE:ERIS) Shares

Jan 17
Read This Before Buying Eris Lifesciences Limited (NSE:ERIS) Shares

Our View On Eris Lifesciences' (NSE:ERIS) CEO Pay

Dec 30
Our View On Eris Lifesciences' (NSE:ERIS) CEO Pay

Hissedar Getirileri

ERISIN PharmaceuticalsIN Pazar
7D4.3%2.6%2.3%
1Y54.3%59.1%37.9%

Getiri vs. Endüstri: ERIS geçen yıl % 59.1 oranında getiri sağlayan Indian Pharmaceuticals sektörünün gerisinde kaldı.

Getiri vs Piyasa: ERIS geçen yıl % 37.9 oranında getiri sağlayan Indian Piyasasını aştı.

Fiyat Oynaklığı

Is ERIS's price volatile compared to industry and market?
ERIS volatility
ERIS Average Weekly Movement4.4%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.4%
10% least volatile stocks in IN Market4.0%

İstikrarlı Hisse Senedi Fiyatı: ERIS son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: ERIS 'nin haftalık oynaklığı ( 4% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
20073,620Amit Bakshiwww.eris.co.in

Eris Lifesciences Limited, iştirakleri ile birlikte Hindistan'da kronik ve alt-kronik tedaviler için yerli markalı formülasyonlar sunmaktadır. Şirket, anti-diyabet, kardiyovasküler, beslenme, dermatoloji, nörobilim, jinekoloji, nefroloji ve onkolojinin yanı sıra merkezi sinir sistemi, kadın sağlığı ve vitaminler/mineraller/besinler gibi çeşitli terapötik alanlarda çeşitli markalı formülasyonlar sunmaktadır. Ayrıca, ambulatuvar kan basıncı ölçümü, ambulatuvar elektrokardiyogram ölçümü, sürekli glikoz izleme sistemi, uyku çalışması ve doğum öncesi bakım çözümleri dahil olmak üzere hasta bakım hizmetleri de sunmaktadır.

Eris Lifesciences Limited Temel Bilgiler Özeti

Eris Lifesciences'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
ERIS temel i̇stati̇sti̇kler
Piyasa değeri₹183.35b
Kazançlar(TTM)₹3.48b
Gelir(TTM)₹24.85b

52.6x

F/K Oranı

7.4x

P/S Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
ERIS gelir tablosu (TTM)
Gelir₹24.85b
Gelir Maliyeti₹5.90b
Brüt Kâr₹18.95b
Diğer Giderler₹15.47b
Kazançlar₹3.48b

Son Raporlanan Kazançlar

Sep 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)25.60
Brüt Marj76.25%
Net Kâr Marjı14.02%
Borç/Özkaynak Oranı84.8%

ERIS uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün